CFTR and cystic fibrosis: For in vivo CFTR editing in the lungs of individuals with CF, effective gene therapy necessitates targeting either CFTR-expressing cells or the lung stem/progenitor cells, which sustain epithelial homeostasis and regenerate the CFTR-expressing cell populations.